CATALOGO DEI PRODOTTI DELLA RICERCA

TECCHIO, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.022
EU - Europa 3.699
AS - Asia 1.815
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
AF - Africa 7
Totale 9.568
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.994
GB - Regno Unito 1.329
CN - Cina 1.105
SG - Singapore 434
IT - Italia 399
DE - Germania 367
SE - Svezia 355
FR - Francia 323
IE - Irlanda 297
RU - Federazione Russa 290
FI - Finlandia 180
JP - Giappone 79
UA - Ucraina 77
VN - Vietnam 51
BE - Belgio 31
KR - Corea 30
CA - Canada 24
ID - Indonesia 22
IN - India 22
IR - Iran 18
TR - Turchia 16
HK - Hong Kong 15
NL - Olanda 8
AU - Australia 7
ES - Italia 7
CH - Svizzera 6
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
AZ - Azerbaigian 4
EU - Europa 4
IL - Israele 4
TG - Togo 4
AR - Argentina 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
PL - Polonia 3
RO - Romania 3
BG - Bulgaria 2
BR - Brasile 2
CL - Cile 2
JO - Giordania 2
LV - Lettonia 2
MX - Messico 2
NO - Norvegia 2
PE - Perù 2
PK - Pakistan 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
CR - Costa Rica 1
GR - Grecia 1
IQ - Iraq 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 9.568
Salva come PNG Salva come JPEG
Città #
Southend 1.228
Chandler 705
Jacksonville 577
Ashburn 415
Woodbridge 391
Singapore 345
Ann Arbor 327
Dublin 292
Houston 200
Beijing 178
Verona 138
Wilmington 114
Jinan 111
Lawrence 108
Princeton 108
Nanjing 86
Shenyang 81
New York 80
Hebei 69
Milan 45
Changsha 43
Sindelfingen 41
Tianjin 40
Nanchang 36
Boardman 35
Dong Ket 33
Helsinki 33
Brussels 31
Haikou 30
Ningbo 30
Taizhou 30
Taiyuan 29
Zhengzhou 28
Seattle 27
Guangzhou 26
Hangzhou 26
Jiaxing 24
Dearborn 23
Redmond 23
Jakarta 21
Kent 21
Seoul 21
Fuzhou 19
Santa Clara 19
Norwalk 18
Bologna 17
Lanzhou 17
Düsseldorf 16
Redwood City 16
Dallas 15
Nürnberg 15
Hong Kong 14
Lancaster 14
Tokyo 14
Fairfield 13
Los Angeles 12
Chicago 10
Leawood 9
Moscow 9
Falls Church 8
Lappeenranta 8
Paris 8
San Francisco 8
San Mateo 8
Seongbuk-gu 8
Shanghai 8
Shinchiba 8
Toronto 8
Zanjan 8
Auburn Hills 7
Frankfurt am Main 7
Tsukuba 7
Washington 7
Châtenay-Malabry 6
Munich 6
Cormano 5
Renton 5
Verdun 5
Amritsar 4
Baku 4
Dongguan 4
Fremont 4
Lomé 4
Montichiari 4
Montreal 4
Newark 4
Philadelphia 4
Phoenix 4
Vienna 4
Asiago 3
Barcelona 3
Bari 3
Buenos Aires 3
Cambridge 3
Carmignano di Brenta 3
Clearwater 3
Cleveland 3
Columbus 3
Elora 3
Kemerovo 3
Totale 6.708
Salva come PNG Salva come JPEG
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 367
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 356
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 158
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 138
Unusual case of solitary intraparenchymal brain plasmacytoma. 135
NEUROLOGICAL COMPLICATIONS IN ADULT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: RESULTS FROM A RETROSPECTIVE MULTICENTRE STUDY 128
Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells 128
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 127
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 124
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 122
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 121
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 118
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 116
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 116
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 113
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 granulocytopenic patients with hematological malignancies 110
Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical zeta isoform of protein kinase C in cancer cell movement 110
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 110
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 110
Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages 108
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 107
Neutrophil-derived cytokines: facts beyond expression 106
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 106
Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol 103
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. 102
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 101
ANTI-MÜLLERIAN HORMONE AND ANTRAL FOLLICLE COUNT REVEAL A LATE IMPAIR- MENT OF OVARIAN RESERVE IN PATIENTS UNDERGONE LOW GONADOTOXIC REGIMENS FOR HAEMATOLOGICAL MALIGNANCIES 101
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 101
Effects of sodium selenite on in vitro interactions between platelets and endothelial cells 100
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia 98
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 97
Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. 96
Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies 96
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 96
Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolation. 95
Hyperchidam Verona897 Regimen Is Effective in Treatment of Advanced Peripheral T Cell Lymphoma (PTCL): The GITIL Experience in 33 Cases 95
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 95
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma 94
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 94
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 94
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 94
Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia 92
Human neutrophils in the saga of cellular heterogeneity: insights and open questions. 90
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 90
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease 89
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 89
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma 87
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 87
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 87
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 87
Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. 86
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 86
Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia. 84
Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. 83
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 83
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 82
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications 80
IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. 79
Membrane and soluble antigens and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 79
Primary mediastinal large B-cell lymphoma (PML-BCL):long term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B 78
On the Cytokines Produced by Human Neutrophils in Tumors. 78
Utility of anti-mullerian hormone for the evaluation of fertility preservation in female patients after chemotherapy [Determinazione dell'ormone anti-mulleriano per la valutazione della riserva ovarica in pazienti dopo trattamento chemioterapico] 78
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 77
PBX/E2A transcript positive B-lymphoblastic leukemia (B-ALL) presenting with bilateral renal and myocardial involvement: a case report. 76
Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies 76
Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: evidence of simultaneous expansion of two independent clones 73
Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia 73
Antimicrobial resistance of Gram-negative bacteria isolated from blood in HSCT patients: a multinational prospective study on behalf of the EBMT-IDWP. 73
Synthetic PGI-2 (Iloprost) treatment in patients with resistant sclerodermic chronic GVHD (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation 73
Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia 73
Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897) 72
The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis 72
SIMILAR BUT NOT THE SAME: CHROMOSOMAL ABNORMALITIES T(8;21)(Q22;Q22) AND INV(16)(P13;Q22)/T(16;16)(P13;Q22) IDENTIFY SUBTYPES OF CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA CHARACTERIZED BY DIFFERENT SURVIVAL AND PROGNOS- TIC FACTORS 72
IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES 72
HER-1 Transactivation by monocyte and cancer cell 7-TMD receptors 71
HB-EGF/HER -1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and preventing reversibly multi-lineage differentiation 70
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 70
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large cell lymphoma 69
HB-EGF/HER -1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and preventing reversibly multi-lineage differentiation 69
The National Institutes of Health criteria for classification and scoring of chronic graft versus host disease: long-term follow-up of a single center series. 68
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up. 68
On the persistence of the primitive chronic myeloid leukaemia cell in patients in complete molecular response 68
Neutrophil-derived chemokines on the road to immunity 67
Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim Versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients With Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation 67
Rituximab-CHOP or two-weekly CHOP +G-CSF in aggressive lymphoma of the ederly ? 67
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 66
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia 62
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 60
Primary Pancreatic Lymphoma: Clinical Presentation, Diagnosis, Treatment and Outcome 59
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 59
A Disseminated Mycobacterium Abscessus Infection in a Patient Affected by Pulmonary Graft versus Host Disease: Case Report with a Revision of Literature 59
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 57
The cross-talk between myeloid and mesenchymal stem cells of human bone marrow represents a biomarker of aging that regulates immune response and bone reabsorption 56
null 55
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 55
HB-EGF/HER -1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and preventing reversibly multi-lineage differentiation 54
Correction: Long-term Outcome After Allogeneic Hematopoietic Stem Cell Transplantation for Shwachman-Diamond Syndrome: A Retrospective Analysis and a Review of the Literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT) 48
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 46
Results of allogeneic stem cell transplantation in patients affected by Shwachman-Diamond syndrome. A retrospective study of SAA-EBMT 45
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience 45
Totale 9.222
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.280
article - articoli 26.101
book - libri 0
conference - conferenze 5.891
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 288
Totale 64.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020804 0 0 0 0 114 155 96 70 57 107 67 138
2020/2021998 91 179 48 140 104 110 11 57 64 6 122 66
2021/20221.052 73 300 5 78 45 20 17 55 41 116 105 197
2022/20231.957 141 197 164 363 173 495 13 126 216 12 35 22
2023/20241.267 39 89 87 98 91 179 65 315 9 50 167 78
2024/2025908 152 142 116 464 34 0 0 0 0 0 0 0
Totale 9.732